Figure 1

PET scans on patient 10121002 in this trial. The top row includes imaging scans performed while the patient was on active therapy, and the bottom row includes imaging scans off therapy. The patient had multiple FDG positive metastases at baseline that responded by the PET scan performed 3 months later and has continued on a durable response for over 3 years.